NO990283L - Formulering for behandling og/eller profylakse av demens - Google Patents

Formulering for behandling og/eller profylakse av demens

Info

Publication number
NO990283L
NO990283L NO990283A NO990283A NO990283L NO 990283 L NO990283 L NO 990283L NO 990283 A NO990283 A NO 990283A NO 990283 A NO990283 A NO 990283A NO 990283 L NO990283 L NO 990283L
Authority
NO
Norway
Prior art keywords
dementia
treatment
prophylaxis
formulation
pharmaceutically acceptable
Prior art date
Application number
NO990283A
Other languages
English (en)
Other versions
NO990283D0 (no
Inventor
Dirk Marinus J Van Schie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO990283D0 publication Critical patent/NO990283D0/no
Publication of NO990283L publication Critical patent/NO990283L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives en farmasøytisk blanding for administrasjon på huden og som omfatter [R-(Z)]-a-(metoksyimino)-cx-(1-azabicyklo[2.2.2]okt-3-yl)-acetonitril eller et farmasøytisk akseptabelt salt derav, sammen med en passende farmasøytisk akseptabel bærer, til behandling eller forebyggelse av demens.
NO990283A 1996-07-25 1999-01-22 Formulering for behandling og/eller profylakse av demens NO990283L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615628.6A GB9615628D0 (en) 1996-07-25 1996-07-25 Formulation
PCT/EP1997/003872 WO1998004258A1 (en) 1996-07-25 1997-07-14 Formulation for the treatment and/or prophylaxis of dementia

Publications (2)

Publication Number Publication Date
NO990283D0 NO990283D0 (no) 1999-01-22
NO990283L true NO990283L (no) 1999-03-19

Family

ID=10797487

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990283A NO990283L (no) 1996-07-25 1999-01-22 Formulering for behandling og/eller profylakse av demens

Country Status (24)

Country Link
EP (1) EP0918521B1 (no)
JP (1) JP2000515868A (no)
KR (1) KR20000029523A (no)
CN (1) CN1226163A (no)
AR (1) AR007983A1 (no)
AT (1) ATE224711T1 (no)
BR (1) BR9710546A (no)
CA (1) CA2261233A1 (no)
CO (1) CO5031290A1 (no)
CZ (1) CZ22799A3 (no)
DE (1) DE69715878T2 (no)
DK (1) DK0918521T3 (no)
ES (1) ES2184121T3 (no)
GB (1) GB9615628D0 (no)
HK (1) HK1021314A1 (no)
IL (1) IL128095A (no)
NO (1) NO990283L (no)
NZ (1) NZ333704A (no)
PL (1) PL331283A1 (no)
PT (1) PT918521E (no)
TR (1) TR199900141T2 (no)
TW (1) TW426514B (no)
WO (1) WO1998004258A1 (no)
ZA (1) ZA976592B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815383D0 (en) * 1998-07-15 1998-09-16 Smithkline Beecham Plc Novel method of treatment
MY127097A (en) * 2000-09-27 2006-11-30 Dsm Ip Assets Bv Process for the carbonylation of a conjugated diene
GB0428170D0 (en) * 2004-12-23 2005-01-26 Biopartners Ltd Mono and Combination Therapy
JP7293560B2 (ja) 2017-12-29 2023-06-20 グアンジョウ マキシノベル ファーマシューティカルズ カンパニー リミテッド 芳香族ビニルまたは芳香族エチル系誘導体、その製造方法、中間体、薬物組成物および使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG48315A1 (en) * 1989-04-13 1998-04-17 Beecham Group Plc Novel compounds
MX9300875A (es) * 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
JP2000515868A (ja) 2000-11-28
TR199900141T2 (xx) 1999-03-22
AR007983A1 (es) 1999-11-24
BR9710546A (pt) 1999-08-17
AU3768497A (en) 1998-02-20
TW426514B (en) 2001-03-21
DK0918521T3 (da) 2003-02-03
NZ333704A (en) 2000-06-23
IL128095A (en) 2002-07-25
CO5031290A1 (es) 2001-04-27
EP0918521A1 (en) 1999-06-02
NO990283D0 (no) 1999-01-22
AU721101B2 (en) 2000-06-22
CA2261233A1 (en) 1998-02-05
ATE224711T1 (de) 2002-10-15
HK1021314A1 (en) 2000-06-09
KR20000029523A (ko) 2000-05-25
IL128095A0 (en) 1999-11-30
DE69715878D1 (de) 2002-10-31
WO1998004258A1 (en) 1998-02-05
CN1226163A (zh) 1999-08-18
EP0918521B1 (en) 2002-09-25
DE69715878T2 (de) 2003-05-22
ZA976592B (en) 1999-03-04
ES2184121T3 (es) 2003-04-01
PT918521E (pt) 2003-02-28
PL331283A1 (en) 1999-07-05
GB9615628D0 (en) 1996-09-04
CZ22799A3 (cs) 1999-06-16

Similar Documents

Publication Publication Date Title
AU2725392A (en) Hiv protease inhibitors
CA2179540A1 (en) Accelerated release composition containing bromocriptine
SI0725779T1 (no)
AU1266288A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
UA41355C2 (uk) Засіб для лікування нейро-сніду
UA35604C2 (uk) Фармацевтична композиція з антидепресивною активністю
ATE212837T1 (de) Pharmazeutische zubereitung zur behandlung akuter rhinitiden, enthaltend sympthomimeticum und pantothenol und/oder pantothensäure
ATE219061T1 (de) Huperzin a analoge verbindungen
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
AU1277792A (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts
NO892820L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater.
NO990283L (no) Formulering for behandling og/eller profylakse av demens
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
CA2003981A1 (en) Pharmaceutical compositions and use thereof in the treatment of psoriasis
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
AU6970394A (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
NO922635L (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
GB9323404D0 (en) Pharmaceuticals
AU3429393A (en) Pharmaceutical pentapeptide compositions and methods of use thereof